FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2553399010> ?p ?o ?g. }

• W2553399010 endingPage "3016" @default.
• W2553399010 startingPage "3006" @default.
• W2553399010 abstract "Standard practice for immunosuppressive therapy after renal transplantation is quadruple therapy using antibody induction, low-dose tacrolimus, mycophenolate mofetil, and corticosteroids. Long-term steroid intake significantly increases cardiovascular risk factors with negative effects on the outcome, especially post-transplantation diabetes associated with morbidity and mortality. In this trial, we examined the efficacy and safety parameters of rapid steroid withdrawal after induction therapy with either rabbit antithymocyte globulin (rabbit ATG) or basiliximab in immunologically low-risk patients during the first year after kidney transplantation.In this open-label, multicentre, randomised controlled trial, we randomly assigned renal transplant recipients in a 1:1:1 ratio to receive either basiliximab induction with low-dose tacrolimus, mycophenolate mofetil, and steroid maintenance therapy (arm A), rapid corticosteroid withdrawal on day 8 (arm B), or rapid corticosteroid withdrawal on day 8 after rabbit ATG (arm C). The study was done in 21 centres across Germany. Only participants aged between 18 and 75 years with a low immunological risk who were scheduled to receive a single-organ renal transplant from either a living donor or a deceased donor were considered for enrolment. Patients receiving a second renal transplant were eligible, provided that the first allograft was not lost due to acute rejection within the first year after transplantation. Donor and recipient had to be ABO compatible. Grafts with pre-transplant existing donor-specific human leukocyte antigen (HLA) antibodies were not eligible and the recipients had to have a panel-reactive antibody concentration of 30% or less. Pregnant women and nursing mothers were excluded from the study. The primary endpoint was the incidence of biopsy-proven acute rejection (BPAR) at 12 months. All analyses were done by intention-to-treat. This trial is registered with ClinicalTrials.gov, number NCT00724022.Between Aug 7, 2008, and Nov 30, 2013, 615 patients were randomly assigned to arm A (206), arm B (189), and arm C (192). BPAR rates were not reduced by rabbit ATG (9·9%) compared with either treatment arm A (11·2%) or B (10·6%; A versus C: p=0·75, B versus C p=0·87). As a secondary endpoint, rapid steroid withdrawal reduced post-transplantation diabetes in arm B to 24% and in arm C to 23% compared with 39% in control arm A (A versus B and C: p=0·0004). Patient survival (94·7% in arm A, 97·4% in arm B, and 96·9% in arm C) and censored graft survival (96·1% in arm A, 96·8% in arm B, and 95·8% in arm C) after 12 months were excellent and equivalent in all arms. Safety parameters such as infections or the incidence of post-transplantation malignancies did not differ between the study arms.Rabbit ATG did not show superiority over basiliximab induction for the prevention of BPAR after rapid steroid withdrawal within 1 year after renal transplantation. Nevertheless, rapid steroid withdrawal after induction therapy for patients with a low immunological risk profile can be achieved without loss of efficacy and is advantageous in regard to post-transplantation diabetes incidence.Investigator Initiated Trial; financial support by Astellas Pharma GmbH, Sanofi, and Roche Pharma AG." @default.
• W2553399010 created "2016-11-30" @default.
• W2553399010 creator A5001373461 @default.
• W2553399010 creator A5001498281 @default.
• W2553399010 creator A5002854962 @default.
• W2553399010 creator A5011844200 @default.
• W2553399010 creator A5013496098 @default.
• W2553399010 creator A5016795540 @default.
• W2553399010 creator A5020102383 @default.
• W2553399010 creator A5042484232 @default.
• W2553399010 creator A5048496808 @default.
• W2553399010 creator A5049091055 @default.
• W2553399010 creator A5053365944 @default.
• W2553399010 creator A5071394674 @default.
• W2553399010 creator A5075805176 @default.
• W2553399010 creator A5087456839 @default.
• W2553399010 date "2016-12-01" @default.
• W2553399010 modified "2023-10-14" @default.
• W2553399010 title "Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial" @default.
• W2553399010 cites W1550111394 @default.
• W2553399010 cites W1558311166 @default.
• W2553399010 cites W1665088674 @default.
• W2553399010 cites W166739738 @default.
• W2553399010 cites W1767457120 @default.
• W2553399010 cites W1917835527 @default.
• W2553399010 cites W1988034903 @default.
• W2553399010 cites W1989324824 @default.
• W2553399010 cites W1990827591 @default.
• W2553399010 cites W2000138932 @default.
• W2553399010 cites W2000531481 @default.
• W2553399010 cites W2006211317 @default.
• W2553399010 cites W2008578164 @default.
• W2553399010 cites W2013233763 @default.
• W2553399010 cites W2026860062 @default.
• W2553399010 cites W2037937957 @default.
• W2553399010 cites W2039879537 @default.
• W2553399010 cites W2044000153 @default.
• W2553399010 cites W2045057854 @default.
• W2553399010 cites W2047455089 @default.
• W2553399010 cites W2068154871 @default.
• W2553399010 cites W2072651170 @default.
• W2553399010 cites W2082111678 @default.
• W2553399010 cites W2087317980 @default.
• W2553399010 cites W2120309176 @default.
• W2553399010 cites W2122004550 @default.
• W2553399010 cites W2133169646 @default.
• W2553399010 cites W2138620116 @default.
• W2553399010 cites W2142288396 @default.
• W2553399010 cites W2147663252 @default.
• W2553399010 cites W2148092884 @default.
• W2553399010 cites W2155965977 @default.
• W2553399010 cites W2162541088 @default.
• W2553399010 cites W2170783570 @default.
• W2553399010 doi "https://doi.org/10.1016/s0140-6736(16)32187-0" @default.
• W2553399010 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27871759" @default.
• W2553399010 hasPublicationYear "2016" @default.
• W2553399010 type Work @default.
• W2553399010 sameAs 2553399010 @default.
• W2553399010 citedByCount "116" @default.
• W2553399010 countsByYear W25533990102015 @default.
• W2553399010 countsByYear W25533990102016 @default.
• W2553399010 countsByYear W25533990102017 @default.
• W2553399010 countsByYear W25533990102018 @default.
• W2553399010 countsByYear W25533990102019 @default.
• W2553399010 countsByYear W25533990102020 @default.
• W2553399010 countsByYear W25533990102021 @default.
• W2553399010 countsByYear W25533990102022 @default.
• W2553399010 countsByYear W25533990102023 @default.
• W2553399010 crossrefType "journal-article" @default.
• W2553399010 hasAuthorship W2553399010A5001373461 @default.
• W2553399010 hasAuthorship W2553399010A5001498281 @default.
• W2553399010 hasAuthorship W2553399010A5002854962 @default.
• W2553399010 hasAuthorship W2553399010A5011844200 @default.
• W2553399010 hasAuthorship W2553399010A5013496098 @default.
• W2553399010 hasAuthorship W2553399010A5016795540 @default.
• W2553399010 hasAuthorship W2553399010A5020102383 @default.
• W2553399010 hasAuthorship W2553399010A5042484232 @default.
• W2553399010 hasAuthorship W2553399010A5048496808 @default.
• W2553399010 hasAuthorship W2553399010A5049091055 @default.
• W2553399010 hasAuthorship W2553399010A5053365944 @default.
• W2553399010 hasAuthorship W2553399010A5071394674 @default.
• W2553399010 hasAuthorship W2553399010A5075805176 @default.
• W2553399010 hasAuthorship W2553399010A5087456839 @default.
• W2553399010 hasConcept C126322002 @default.
• W2553399010 hasConcept C141071460 @default.
• W2553399010 hasConcept C168563851 @default.
• W2553399010 hasConcept C2776715498 @default.
• W2553399010 hasConcept C2776804153 @default.
• W2553399010 hasConcept C2779978075 @default.
• W2553399010 hasConcept C2780252810 @default.
• W2553399010 hasConcept C2780303639 @default.
• W2553399010 hasConcept C2781307858 @default.
• W2553399010 hasConcept C2909675724 @default.
• W2553399010 hasConcept C2911091166 @default.
• W2553399010 hasConcept C64518967 @default.
• W2553399010 hasConcept C71924100 @default.
• W2553399010 hasConcept C90924648 @default.
• W2553399010 hasConceptScore W2553399010C126322002 @default.

• next